Clover Health Investments, Corp. - Class A Common stock (CLOV) Covered Calls

Clover Health is a physician enablement technology company focused on providing Medicare Advantage plans and care-management software. The company utilizes its proprietary AI-powered platform, Clover Assistant, to aggregate patient data and deliver real-time clinical insights to primary care physicians. By identifying chronic conditions earlier and optimizing treatment plans, Clover aims to improve health outcomes and lower medical costs for the senior population across the United States.

You can sell covered calls on Clover Health Investments, Corp. - Class A Common stock to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for CLOV (prices last updated Mon 4:16 PM ET):

Want to make money with covered calls?  Sign Up For A Free Trial

Clover Health Investments, Corp. (CLOV) is a next-generation healthcare technology company that operates primarily as a Medicare Advantage (MA) insurer. The core of its value proposition is the Clover Assistant, a sophisticated AI-driven software platform designed to sit at the point of care. By synthesizing data from across the healthcare spectrum—including lab results, pharmacy records, and specialist notes—the Assistant provides primary care physicians with actionable, evidence-based recommendations to manage chronic diseases like diabetes and chronic kidney disease more effectively.

As of early 2026, Clover has pivoted toward a "Software-plus-Services" model through its subsidiary, Counterpart Health. This strategic arm extends the benefits of Clover’s technology to external payors and health systems, allowing them to utilize the Clover Assistant on a software-as-a-service (SaaS) basis. This diversification reduces the company’s absolute dependence on insurance premiums and capitalizes on the industry shift toward value-based care. The company’s insurance segment focuses on high-choice PPO plans, which represent over 95% of its 150,000+ member base and consistently score top-tier HEDIS quality ratings.

Competitive Landscape

Clover Health operates in the highly competitive Medicare Advantage market, contending with both legacy insurance giants and "insurtech" newcomers. Its primary public peers in the technology-enabled healthcare space include Oscar Health and Alignment Healthcare, both of which are listed on major exchanges and feature active options chains. These firms similarly leverage proprietary data platforms to drive member engagement and clinical efficiency.

In the broader insurance market, Clover faces massive scale competition from UnitedHealth Group and Humana. While these incumbents have vast resources, Clover differentiates itself by maintaining an open-network PPO model that provides seniors more provider flexibility. In the physician enablement and value-based care sector, the company also tracks against firms like Hims & Hers Health and HealthEquity for consumer-driven healthcare mindshare. Despite the presence of large rivals, Clover’s specific focus on the 2026 "Counterpart" SaaS expansion has created a unique niche within the healthcare provider landscape.

Strategic Outlook and Innovation

The company’s 2026 strategic roadmap is defined by its expected transition to full-year GAAP net income profitability. This goal is being driven by the "compound earnings" effect of its returning member cohorts, which typically exhibit lower medical cost ratios (MCR) as their care is optimized over time by the Clover Assistant. Management is also prioritizing SG&A leverage, using internal AI automation to reduce the overhead associated with claims processing and member services, which is expected to drive significant margin expansion through 2027.

Innovation continues to center on the expansion of the "Home Care" program, which integrates remote patient monitoring and palliative care services directly into the Clover Assistant ecosystem. By early 2026, the company has integrated advanced generative AI features that allow physicians to instantly summarize years of patient history and flag high-risk "rising risk" patients before acute medical events occur. These advancements, combined with a disciplined geographic focus in core markets, are intended to insulate Clover from CMS Star Rating fluctuations and establish it as a premier clinical technology partner in the evolving U.S. healthcare system.

Want more examples? CLOU Covered Calls | CLS Covered Calls